Skip to main navigation Skip to main content
Home
Consumer Healthcare Products Association
Taking healthcare personally.

User account menu

  • About CHPA
  • Membership
  • CHPA Educational Foundation
  • Career Center
  • Login
  • Our Issues
      1. OTC Medicines
        1. Acetaminophen
        2. Children's Cough and Cold Medicines
        3. DXM (dextromethorphan)
        4. Monograph Reform
        5. OTC Distribution
        6. Pediatrics Medicine
        7. PSE (Pseudoephedrine)
        8. RX-to-OTC Switch
        9. Sunscreen
        10. Triclosan
      2. Dietary Supplements
        1. CBD and Hemp Oil
        2. DSHEA
        3. Immunity
        4. New Dietary Ingredients
        5. Probiotics
        6. Vitamins and Minerals
      3. Consumer Medical Devices
        1. 510(K) Modifications
        2. Device Classification
      4. Other Issues
        1. Branding
        2. COVID-19
        3. Digital Health
        4. FSA/HSA
        5. Health Literacy
        6. Ingredient Safety
        7. Labeling
        8. NPLEx (National Precursor Log Exchange)
        9. Packaging
        10. Proposition 65
        11. Quality
        12. Research
        13. Safe Storage
        14. Sales Tax Exemption
        15. Supply Chain
        16. Sustainability
        17. Take Back/Drug Disposal
  • Public Policy & Regulatory
      1. Regulation
        1. Regulation of OTC Medicines
        2. Regulation of Dietary Supplements
        3. Regulation of Consumer Medical Devices
        4. Submissions
        5. FDA Annual Forecast
      2. Voluntary Codes and Guidelines
      3. Legislative Priorities
        1. Federal Legislative Priorities
        2. State & Local Legislative Priorities
        3. Congressional Dietary Supplement Caucus
        4. State Government Reports
  • Events & Education
      1. CHPA Academy
        1. Consumer Healthcare 101
      2. Marketing Conference
      3. Regulatory, Scientific & Quality Conference
      4. CHPA Educational Foundation Gala
        1. Self-Care Marketing Awards
      5. Become A Sponsor
  • About Consumer Healthcare
      1. Research & Data
        1. OTC Sales Statistics
        2. Consumer Medical Device Statistics
        3. Dietary Supplement Resource Library
        4. Research Reports
      2. Multimedia
        1. Podcast
        2. Videos
        3. Infographics
      3. Activities & Initiatives
        1. Preventing Dextromethorphan Abuse
        2. Preventing Illegal Meth Production
        3. Safe Use of Acetaminphen
        4. Tax Free OTC
        5. The Value of OTC Medicines
      4. FAQs
  • News
Open Search
Open Menu

Main navigation

  • Our Issues
    • OTC Medicines
      • Acetaminophen
      • Children's Cough and Cold Medicines
      • DXM (dextromethorphan)
      • Monograph Reform
        • User Fees
      • OTC Distribution
      • Pediatrics Medicine
      • PSE (Pseudoephedrine)
      • RX-to-OTC Switch
      • Sunscreen
      • Triclosan
    • Dietary Supplements
      • CBD and Hemp Oil
      • DSHEA
      • Immunity
      • New Dietary Ingredients
      • Probiotics
      • Vitamins and Minerals
    • Consumer Medical Devices
      • 510(K) Modifications
      • Device Classification
    • Other Issues
      • Branding
      • COVID-19
      • Digital Health
      • FSA/HSA
      • Health Literacy
      • Ingredient Safety
      • Labeling
      • NPLEx (National Precursor Log Exchange)
      • Packaging
      • Proposition 65
      • Quality
      • Research
      • Safe Storage
      • Sales Tax Exemption
      • Supply Chain
      • Sustainability
      • Take Back/Drug Disposal
  • Public Policy & Regulatory
    • Regulation
      • Regulation of OTC Medicines
        • Child-Resistant Packaging
        • Drug Distribution and National Uniformity
        • OTC Drug Advertising
        • Structured Product Labeling
      • Regulation of Dietary Supplements
        • Dietary Supplement Safety
        • Labeling Dietary Supplements
        • Marketing and Advertising Dietary Supplements
        • Standardized Information on Dietary Ingredients (SIDI)
      • Regulation of Consumer Medical Devices
      • Submissions
      • FDA Annual Forecast
        • Risks Associated with Codeine-Containing Cough Medicine
        • Pediatric Acetaminophen Dosing
        • Risks Associated with Propylhexedrine Abuse and Misuse
        • Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Oligohydramnios
        • Oral Healthcare in Infants and Children - Benzocaine and/or Phenol Preparations
        • Proposed Safety Administrative Order for Serious Skin reactions Associated with Acetaminophen
        • Anticaries Test Methods
    • Voluntary Codes and Guidelines
    • Legislative Priorities
      • Federal Legislative Priorities
      • State & Local Legislative Priorities
      • Congressional Dietary Supplement Caucus
      • State Government Reports
  • Events & Education
    • CHPA Academy
      • Consumer Healthcare 101
    • Marketing Conference
    • Regulatory, Scientific & Quality Conference
    • CHPA Educational Foundation Gala
      • Self-Care Marketing Awards
    • Become A Sponsor
  • About Consumer Healthcare
    • Research & Data
      • OTC Sales Statistics
      • Consumer Medical Device Statistics
      • Dietary Supplement Resource Library
      • Research Reports
    • Multimedia
      • Podcast
      • Videos
      • Infographics
    • Activities & Initiatives
      • Preventing Dextromethorphan Abuse
      • Preventing Illegal Meth Production
      • Safe Use of Acetaminphen
      • Tax Free OTC
      • The Value of OTC Medicines
    • FAQs
  • News

User account menu

  • About CHPA
  • Membership
  • CHPA Educational Foundation
  • Career Center
  • Login
  • LinkedIn
  • YouTube
  • Twitter
  • Facebook

Breadcrumb

  1. Home
  2. Public Policy & Regulatory
  3. Regulation
  4. Submissions
  5. Letter to Attorney General Regarding Tainted Dietary Supplements

Letter to Attorney General Regarding Tainted Dietary Supplements

Share page:
Download Document
Issues:
Dietary Supplements
Other Issues
Ingredient Safety

Related Posts

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Expresses Concerns with Dietary Supplement Provisions in just-introduced FDA Safety and Landmark Advancement (FDASLA) Act of 2022

May 27, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, Friday, May 27, 2022

May 25, 2022

three Dietary Supplement Powders in scoops

Press Releases and Statements

CHPA Reiterates Call for Additional Measures on Dietary Supplement Provisions in Draft User Fee Reauthorization Package

May 18, 2022

Consumer Healthcare Products Association | Taking healthcare personally.

  • LinkedIn
  • YouTube
  • Twitter
  • Facebook

Consumer Healthcare Products Association
1625 Eye Street, NW, Suite 600
Washington, DC 20006
T: 202.429.9260
F: 202.223.6835

About Us

  • Careers at CHPA
  • Contact Us
  • Our Members
  • Our Team

Quick Links

  • KnowYourOTCs
  • Know Your Dose
  • Up and Away
  • Annual Report

© 2022 Consumer Healthcare Products Association - CHPA. All Rights Reserved

Footer

  • Privacy Policy
  • Terms of Use
  • Sitemap